Should I buy Dorman Products, Inc. (DORM) stock or is it too late?
No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.
Firm-by-firm track record on Dorman Products, Inc.
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Barrington Research | 80 % | +12.3 % | 5 | $150 +17% |
✅ Reasons to believe
- 100% of analysts rate it a buy (Buy consensus, 5 ratings) — a sign of market conviction.
- Median price target $150, i.e. +17% from the current price ($128).
- The most reliable firm on DORM, Barrington Research (80% hit rate, 5 scored calls), targets $150 (call made on May 4, 2026, maturing on May 4, 2027) (+17%) in its most recent call, and $150 (call made on March 5, 2026, maturing on March 5, 2027) (+17%) in the one coming due soonest.
⚠️ Reasons to hesitate
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- Volatile stock: sharp swings — including steep drops — are part of its profile.
- No dividend: your return depends only on price appreciation.
- A near-unanimous consensus leaves little room for positive surprise — a lot of optimism is already baked in.
The analyst consensus on DORM
Median target $150 (+17%) · 5 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Dorman Products, Inc. now?
We won't decide for you. The facts: 100% of analysts rate it a buy, median target $150 (+17%), and Barrington Research (most reliable on DORM, 80%) targets $150. Weigh that against valuation and volatility. This is not personalized advice.
Is it too late to invest in Dorman Products, Inc.?
Not according to analysts: the median target ($150) is still +17% above the current price ($128) (most reliable on DORM: Barrington Research, 80%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Dorman Products, Inc. still worth investing in?
It depends on the gap between the price ($128) and its estimated value: analysts target $150 on median (+17%), with 100% buys (most reliable on DORM: Barrington Research, 80%). Cross-check with their real reliability on DORM and the cautions above. Information, not advice.
What's the main risk in buying DORM?
A 12-month target is not a guaranteed path: the price can fall in the meantime.
→ Go deeper: the full Dorman Products, Inc. profile (consensus, analyst reliability, price target, performance).